Advertisement

Topics

Servier to buy Shire's oncology business for $2.4bn

06:26 EDT 16 Apr 2018 | Pharmaceutical Business Review

French pharmaceutical firm Servier has signed an agreement to acquire the oncology business of Shire for $2.4bn.

Original Article: Servier to buy Shire's oncology business for $2.4bn

NEXT ARTICLE

More From BioPortfolio on "Servier to buy Shire's oncology business for $2.4bn"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...